[Creative mathematics with clopidogrel; exaggeration of the preventive effect by the pharmaceutical company].
Walvoort
H C
HC
D000329:Advertising / Q000592:standards; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000517:prevention & control*; D001241:Aspirin / Q000627:therapeutic use*; D000077144:Clopidogrel; D003627:Data Interpretation, Statistical; D006801:Humans; D008433:Mathematics; D009426:Netherlands; D015990:Placebo Effect; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin